Basic Information
VORTIOSON FILM-COATED TABLET 5MG
TABLET, FILM COATED
Regulatory Information
SIN16557P
July 20, 2022
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XN06AX26
Company Information
Active Ingredients
Vortioxetine hydrobromide eqv Vortioxetine
Strength: 5 mg
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_. Concomitant use with nonselective monoamine oxidase inhibitors (MAOIs) or selective MAO-A inhibitors (see section 4.5 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).
Indication Information
**4.1 Therapeutic indications** Vortioson is indicated for the treatment of major depressive episodes in adults.